Clinical Trial Update: Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating inhaled exosome therapy for safety and efficacy in COVID-19–associated pneumonia has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov-2 Pneumonia

Snippet

Sponsor: State-Financed Health Facility "Samara Regional Medical Center Dinasty" | Conditions: Covid19, SARS-CoV-2 PNEUMONIA | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-11-04